非酒精性脂肪肝或将有新疗法

文章来源:酒精性脂肪肝   发布时间:2016-11-24 23:01:16   点击数:
 

ResearchersreportinthejournalCellReportsatargetedmolecular1therapythatdramaticallyreducestheinitialdevelopmentofNonAlcoholic2FattyLiverDisease(NAFLD)inlaboratorymousemodelsofthedisease.Thestudy,publishedonlineJune30,foundincreasedlevelsofanenzyme3calledcdk4inpatientswithNAFLDandinmousemodels.ResearchersatCincinnatiChildrensHospitalMedicalCenterreportthatwhentheyusedtwodrugsthatinhibit4cdk4inmousemodelsofNAFLD(flavopiridol,PD-),thissignificantlyreduceddevelopmentofhepaticsteatosis-thefirststageofthedisease.

Thisisthefirststudytoshowthatcdk4triggersdevelopmentofNAFLDandthatinhibiting5thisenzymecanbothpreventandreversethefirststepofthedisease,saidNikolaiTimchenko,PhD,seniorauthorandheadoftheLiverTumor6BiologyProgramatCincinnatiChildrens.Bothofthecdk4inhibitorswetestedareapprovedbytheFDAandinclinicaltrialsforlivercancer,soitshouldbepossibletoinitiate7clinicaltrialsforNAFLDwiththesedrugssoon.

NAFLDisanabnormalbuildupofextrafatinlivercellsthatisnotcausedbyalcohol.Thedisease-whichaffectsupto25percentoftheU.S.population-usuallydevelopsinpeoplewhoareoverweight,obese8orhavediabetes9andhighcholesterol10.Thefirststageofthedisease,hepaticsteatosis,canprogresstoaconditioncalledNASH(non-alcoholicsteatohepatitis)andultimatelycirrhosisorlivercancer.

TimchenkosaidnewtherapiesforNAFLDareneededbecause,shortofweightlossandlifestylechanges,therecurrentlyarenosafeoreffectivetreatments.Therearenewtreatmentsbeingtestedinclinicaltrialswithpromising11results,butthesestudieshaverevealedevidenceofserioussideeffects.

1molecular

adj.分子的;克分子的

参考例句:

Theresearchwillprovidedirectinsightintomolecularmechanisms.这项研究将使人能够直接地了解分子的机理。

Forthepressuretobe







































北京治疗白癜风一共需要多少钱
北京最好的白癜风医院咨询

转载请注明:http://www.midaotuan.com/xgyy/1615.html